Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$907M |
| 2 |
Apple
AAPL
|
+$260M |
| 3 |
Microsoft
MSFT
|
+$223M |
| 4 |
Amazon
AMZN
|
+$173M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$471M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$177M |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$160M |
| 4 |
Petrobras
PBR
|
+$153M |
| 5 |
Adobe
ADBE
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.79% |
| 2 | Healthcare | 12.41% |
| 3 | Financials | 9.98% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Communication Services | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
501
Petrobras Class A
PBR.A
$106B
| $1.75M | ﹤0.01% |
164,202
| – | – |
|
502
State Street Financial Select Sector SPDR ETF
XLF
$58.5B
| $1.74M | ﹤0.01% |
55,163
+13
| +0% | +$449 |
|
503
Ross Stores
ROST
$81B
| $1.73M | ﹤0.01% |
24,606
+3,245
| +15% | +$289K |
|
|
IMGN
504
DELISTED
Immunogen Inc
IMGN
| $1.72M | ﹤0.01% |
381,206
+722
| +0.2% | +$3.14K |
|
505
Sherwin-Williams
SHW
$88.7B
| $1.71M | ﹤0.01% |
7,647
-4,066
| -35% | -$1.04M |
|
506
SPS Commerce
SPSC
$2.58B
| $1.69M | ﹤0.01% |
+14,953
| New | +$1.69M |
|
|
KYO
507
DELISTED
Kyocera Adr
KYO
| $1.69M | ﹤0.01% |
31,637
-5,265
| -14% | -$281K |
|
508
Ironwood Pharmaceuticals
IRWD
$716M
| $1.67M | ﹤0.01% |
144,786
+269
| +0.2% | +$3.17K |
|
|
MNTV
509
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $1.67M | ﹤0.01% |
189,629
-18,487
| -9% | -$247K |
|
510
Hormel Foods
HRL
$13.8B
| $1.65M | ﹤0.01% |
34,862
+90
| +0.3% | +$4.49K |
|
511
Qualys
QLYS
$6.53B
| $1.64M | ﹤0.01% |
+13,019
| New | +$1.71M |
|
512
FIVE9
FIVN
$2.26B
| $1.63M | ﹤0.01% |
+17,932
| New | +$1.81M |
|
513
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.51B
| $1.63M | ﹤0.01% |
46,869
+347
| +0.7% | +$13.2K |
|
514
iShares US Pharmaceuticals ETF
IHE
$1.64B
| $1.61M | ﹤0.01% |
25,248
-870
| -3% | -$55.2K |
|
515
Travere Therapeutics
TVTX
$5.86B
| $1.61M | ﹤0.01% |
66,362
-83
| -0.1% | -$2.09K |
|
516
iShares US Telecommunications ETF
IYZ
$1.24B
| $1.6M | ﹤0.01% |
63,609
+43,476
| +216% | +$1.18M |
|
517
iShares Europe ETF
IEV
$1.69B
| $1.59M | ﹤0.01% |
37,129
-642
| -2% | -$30K |
|
518
AnaptysBio
ANAB
$1.63B
| $1.57M | ﹤0.01% |
77,540
+9,651
| +14% | +$214K |
|
|
INN
519
Summit Hotel Properties
INN
$740M
| $1.57M | ﹤0.01% |
215,551
+156,596
| +266% | +$1.38M |
|
520
Boot Barn
BOOT
$4.84B
| $1.56M | ﹤0.01% |
22,605
-17
| -0.1% | -$1.46K |
|
521
Manhattan Associates
MANH
$11.1B
| $1.54M | ﹤0.01% |
+13,415
| New | +$1.67M |
|
522
Invesco China Technology ETF
CQQQ
$3.17B
| $1.52M | ﹤0.01% |
30,222
+8,981
| +42% | +$405K |
|
523
iShares Core S&P 500 ETF
IVV
$899B
| $1.51M | ﹤0.01% |
3,996
-6,217
| -61% | -$2.56M |
|
|
DAY
524
DELISTED
Dayforce
DAY
| $1.5M | ﹤0.01% |
+31,963
| New | +$1.77M |
|
|
SPR
525
DELISTED
Spirit AeroSystems
SPR
| $1.5M | ﹤0.01% |
51,329
-70,778
| -58% | -$2.53M |
|
Similar funds
Ken Fisher's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Fisher held 1,196 positions worth $141B, down 17% from $169B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Fisher's Q2 2022 filing shows 110 new, 483 increased, 318 reduced and 131 closed positions. Its largest new stake was Woodside Energy: 6,156,348 shares worth $133M. The largest sale was Eli Lilly, an estimated $471M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.
- Ken Fisher's largest Q2 2022 buy was Woodside Energy: 6,156,348 shares worth $133M.
- Ken Fisher added most to Johnson & Johnson in Q2 2022, an estimated $907M increase.
- Ken Fisher's biggest Q2 2022 reduction was Eli Lilly, cutting an estimated $471M.
- Ken Fisher fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $160M.
- Ken Fisher's ten largest holdings make up 30% of its $141B portfolio in Q2 2022.
- Ken Fisher opened 110 new positions and closed 131 in Q2 2022.
- Ken Fisher's portfolio value fell 17% quarter-over-quarter to $141B.
Based on Fisher Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.